Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy
Sign Up to like & getrecommendations! Published in 2019 at "Sleep"
DOI: 10.1093/sleep/zsz252
Abstract: Abstract Objectives To evaluate the human abuse potential of pitolisant, a selective histamine 3 (H3)-receptor antagonist/inverse agonist recently approved by the US Food and Drug Administration for the treatment of excessive daytime sleepiness in adult… read more here.
Keywords: pitolisant; receptor antagonist; pitolisant selective; drug ... See more keywords